Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2010 06:00 ET | Source: MediciNova, Inc.

The Clinical Potential and Therapeutic Differentiation of MediciNova's MN-166 Featured in Neurology Articles

SAN DIEGO, April 1, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities...
March 24, 2010 17:10 ET | Source: MediciNova, Inc.

MediciNova Reports Fourth Quarter and Full Year 2009 Results

SAN DIEGO, March 24, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
March 17, 2010 16:30 ET | Source: MediciNova, Inc.

MediciNova Reports Positive Preliminary Results From a Phase Ib Clinical Trial of MN-221 in Moderate to Severe COPD Patients

SAN DIEGO, March 17, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
February 01, 2010 06:00 ET | Source: MediciNova, Inc.

MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer

SAN DIEGO, Feb. 1, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
January 05, 2010 06:00 ET | Source: MediciNova, Inc.

MediciNova Extends Conversion Deadline to January 11, 2010

SAN DIEGO, Jan. 5, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
December 18, 2009 21:00 ET | Source: MediciNova, Inc.

MediciNova Completes Acquisition of Avigen

SAN DIEGO, Dec. 18, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
December 17, 2009 19:40 ET | Source: MediciNova, Inc.

MediciNova and Avigen Stockholders Approve Merger

SAN DIEGO and ALAMEDA, Calif., Dec. 17, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
December 15, 2009 06:00 ET | Source: MediciNova, Inc.

MediciNova and Avigen Confirm Stockholder Election Deadline

SAN DIEGO and ALAMEDA, Calif., Dec. 15, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
December 09, 2009 17:00 ET | Source: MediciNova, Inc.

MediciNova and Avigen Announce Stockholder Election Deadline and Update to Estimated Merger Consideration

SAN DIEGO and ALAMEDA, Calif., Dec. 9, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
November 12, 2009 17:10 ET | Source: MediciNova, Inc.

MediciNova Reports Third Quarter 2009 Results

SAN DIEGO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the...